A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

NCT05345509 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Aricept Tablet
DRUG: IVL3003
DRUG: IVL3003

Sponsor

Inventage Lab., Inc.